https://orcid.org/0000-0002-7837-6580
References
- Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44(2):81–88.
- Gruber LM, Erickson D, Babovic-Vuksanovic D, et al. Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1. Clin Endocrinol (Oxf). 2017;86(1):141–149.
- Madigan P, Shaw RV. Neurofibromatosis in 13th century Austria? Neurofibromatosis. 1988;1(5–6):339–341.
- Antônio JR, Goloni-Bertollo EM, Trídico LA. Neurofibromatosis: chronological history and current issues. An Bras Dermatol. 2013;88(3):329–343.
- Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development conference. Arch Neurol. 1988;45(5):575–578.
- Walker L, Thompson D, Easton D, et al. A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer. 2006;95(2):233–238.
- Rassmussen SA, Yang Q, Friedman JM. Mortality in Neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet. 2001;68(5):1110–1118.
- Dluhy RG. Pheochromocytoma: the death of an axiom. N Engl J Med. 2002;346:1486–1488.
- Hari Kumar KVS, Shaikh A, Sandhu AS, et al. Neurofibromatosis 1 with pheochromocytoma. Indian J Endocrinol Metab. 2011;15(S4):S406–S408.
- King KS, Pacak K. Familial pheochromocytomas and paragangliomas. Mol Cell Endocrinol. 2014;386:92–100.
- Képénékian L, Mognetti T, Lifante JC, et al. Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1. Eur J Endocrinol. 2015;175(4):335–344.
- Petr EJ, Else T. Pheochromocytoma and paraganglioma in Neurofibromatosis type 1: frequent surgeries and cardiovascular crises indicate the need for screening. Clin Diabetes Endocrinol. 2018;4:1.
- Tate JM, Gyroffy JB, Colburn JA. The importance of pheochromocytoma case detection in patients with neurofibromatosis type 1: a case report and review of literature. SAGE Open Med Case Rep. 2017;5:2050313X17741016.
- Plouin P, Amar L, Dekkers OM, et al. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol. 2016;174:G1–10.
- Walther MM, Herring J, Enquist E, et al. von Recklinghausen′s disease and pheochromocytomAS. J Urol. 1999;162(5):1582–1586.